Cargando…
Pharmacologic inhibition of RGD‐binding integrins ameliorates fibrosis and improves function following kidney injury
Fibrosis is a final common pathway for many causes of progressive chronic kidney disease (CKD). Arginine–glycine–aspartic acid (RGD)‐binding integrins are important mediators of the pro‐fibrotic response by activating latent TGF‐β at sites of injury and by providing myofibroblasts information about...
Autores principales: | Basta, Jeannine, Robbins, Lynn, Stout, Lisa, Prinsen, Michael J., Griggs, David W., Rauchman, Michael |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
John Wiley and Sons Inc.
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7153038/ https://www.ncbi.nlm.nih.gov/pubmed/32281744 http://dx.doi.org/10.14814/phy2.14329 |
Ejemplares similares
-
RGD-Binding Integrins in Head and Neck Cancers
por: Ahmedah, Hanadi Talal, et al.
Publicado: (2017) -
Inhibitors of Arg-Gly-Asp-Binding Integrins Reduce Development of Pancreatic Fibrosis in Mice
por: Ulmasov, Barbara, et al.
Publicado: (2016) -
Tuning RGD Motif and Hyaluronan Density to Study Integrin Binding
por: Zapp, Cornelia, et al.
Publicado: (2018) -
Conditional Expression of Wnt9b in Six2-Positive Cells Disrupts Stomach and Kidney Function
por: Kiefer, Susan M., et al.
Publicado: (2012) -
Exploring the Role of RGD-Recognizing Integrins in Cancer
por: Nieberler, Markus, et al.
Publicado: (2017)